BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1

• Press Releases

  Exelixis Announces Appointment of Dana T. Aftab, Ph.D. as Executive Vice President, Research and Development

  September 1, 2025

   · 

  4 min read
• Press Releases

  FDA Approval of Leqembi Subcutaneous Formulation Charts Path to Combination Therapies for Alzheimer’s Disease

  September 1, 2025

   · 

  3 min read
• Press Releases

  Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - August 29, 2025

  September 1, 2025

   · 

  1 min read
• Press Releases

  FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

  September 1, 2025

   · 

  27 min read
• Press Releases

  Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia

  September 1, 2025

   · 

  10 min read
• Press Releases

  Biomerica Reports Fiscal 2025 Year End Results

  September 1, 2025

   · 

  6 min read
• Press Releases

  Equillium to Participate in the Cantor Global Healthcare Conference 2025

  September 1, 2025

   · 

  2 min read
• Press Releases

  Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences

  September 1, 2025

   · 

  1 min read
• Press Releases

  AMGEN TO PRESENT AT THE 2025 WELLS FARGO HEALTHCARE CONFERENCE

  September 1, 2025

   · 

  1 min read
• Press Releases

  Ultragenyx to Participate at Investor Conferences in September 2025

  September 1, 2025

   · 

  1 min read